Tbe authors evaluated the cognitive and psychomotor effects of serotonin re
uptake inhibitors in health elderly volunteers. Paroxetine, sertraline, and
placebo were compared for 3 weeks of testing in a double-blind study with
behavioral testing at baseline and at the end of each week. MANOVA models d
emonstrated no between-group differences; however, mixed-model random regre
ssion analyses revealed that Day 14 plasma paroxetine levels correlated neg
atively with delayed verbal recall and paired-associate learning scores. In
contrast, plasma sertraline levels correlated positively with Day 7 immedi
ate verbal recall, Day 14 tapping, and Day 21 delayed verbal recall scores,
and negatively with divided-attention task scores on Day 21. Plasma paroxe
tine levels were associated with mild behavioral impairment at Day 14, with
no other significant adverse effects. Plasma sertraline levels were associ
ated with mild and transient behavioral changes, as well as early terminati
on in several subjects.